Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations (Q35934073)

11 August 2017

1 reference

title

Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations (English)

1 reference

11 August 2017

1 reference

Murray Joseph Casey

1

1 reference

11 August 2017

Chhanda Bewtra

series ordinal

2

1 reference

11 August 2017

language of work or name

1 reference

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

3-4

1 reference

11 August 2017

page(s)

265-281

1 reference

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

Reduced Incidence of Endometrial Cancer among Postmenopausal Women Treated with Progestogens*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

Tamoxifen, serum lipoproteins and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

Selective estrogen receptor modulators: an alternative to hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-004-9554-Y

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

21 January 2018

1 reference

12 December 2020

Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies

1 reference

12 December 2020

Endometrioid-type cystadenocarcinoma arising in the mesosalpinx

1 reference

12 December 2020

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

1 reference

12 December 2020

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)

1 reference

12 December 2020

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

12 December 2020

Multiple focal extraovarian serous carcinoma

1 reference

12 December 2020

Ovarian Serous Tumors of Low Malignant Potential (Serous Borderline Tumors) The Relationship of Exophytic Surface Tumor to Peritoneal “Implants”

1 reference

12 December 2020

Cancer Incidence in BRCA1 mutation carriers

1 reference

12 December 2020

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Serous borderline tumors of the peritoneum

1 reference

12 December 2020

Current status of prophylactic surgery for hereditary breast and gynecologic cancers

1 reference

12 December 2020

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

12 December 2020

Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Ovarian serous borderline tumors with invasive peritoneal implants

1 reference

12 December 2020

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

12 December 2020

Ovarian surface epithelium: biology, endocrinology, and pathology

1 reference

12 December 2020

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis

1 reference

12 December 2020

Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison

1 reference

12 December 2020

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

12 December 2020

A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma

1 reference

12 December 2020

Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma

1 reference

12 December 2020

BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum

1 reference

12 December 2020

Tubal ligation and fatal ovarian cancer in a large prospective cohort study

1 reference

12 December 2020

Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma

1 reference

12 December 2020

Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease

1 reference

12 December 2020

Broad ligament adenocarcinoma of Müllerian origin

1 reference

12 December 2020

Carcinoma of the Ovary: A Report of 106 Cases: I. A Further Effort at Pathological Differentiation

1 reference

12 December 2020

Papillary peritoneal carcinomatosis after prophylactic oophorectomy

1 reference

12 December 2020

Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma

1 reference

12 December 2020

Serous psammocarcinoma of the ovary and peritoneum

1 reference

12 December 2020

Varieties of serous surface papillary carcinoma of the peritoneum in northern Germany: a thirty-year autopsy study.

1 reference

12 December 2020

Estrogens, progestogens and endometrial cancer

1 reference

12 December 2020

Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier

1 reference

12 December 2020

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

12 December 2020

Ovarian cancer screening. The role of ultrasound in early detection

1 reference

12 December 2020

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma

1 reference

12 December 2020

Risk of Endometrial Carcinoma Associated with BRCA Mutation

1 reference

12 December 2020

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

1 reference

12 December 2020

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

1 reference

12 December 2020

Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma—a Gynecologic Oncology Group Study

1 reference

12 December 2020

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

12 December 2020

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

12 December 2020

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

1 reference

12 December 2020

Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report

1 reference

12 December 2020

Serous Papillary Cystadenoma of Borderline Malignancy of Broad Ligament. A Report of 25 Cases

1 reference

12 December 2020

Ovarian serous borderline epithelial tumors with multiple retroperitoneal nodal involvement: metastasis or malignant transformation of epithelial glandular inclusions?

1 reference

12 December 2020

Serous surface papillary carcinoma of the ovary: a clinical, pathologic, ultrastructural, and immunohistochemical study of 11 cases.

1 reference

12 December 2020

Coronary heart disease mortality and adjuvant tamoxifen therapy

1 reference

12 December 2020

Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy

1 reference

12 December 2020

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases

1 reference

12 December 2020

Precursor lesions of ovarian epithelial malignancy

1 reference

12 December 2020

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

1 reference

12 December 2020

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

12 December 2020

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

1 reference

12 December 2020

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

1 reference

12 December 2020

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

12 December 2020

Cardiovascular trials of estrogen replacement therapy.

1 reference

12 December 2020

Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases

1 reference

12 December 2020

Prognostic factors in extraovarian primary peritoneal carcinoma

1 reference

12 December 2020

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study

1 reference

12 December 2020

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families

1 reference

12 December 2020

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

1 reference

12 December 2020

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel

1 reference

12 December 2020

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

12 December 2020

Long-term follow-up of serous ovarian tumors of low malignant potential

1 reference

12 December 2020

Familial peritoneal ovarian carcinomatosis: a new clinical entity?

1 reference

12 December 2020

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

1 reference

12 December 2020

Serous surface carcinoma of the peritoneum: A clinicopathologic study of 22 cases

1 reference

12 December 2020

Tamoxifen and risk of idiopathic venous thromboembolism

1 reference

12 December 2020

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

1 reference

12 December 2020

Serous borderline tumors of the ovary with noninvasive peritoneal implants

1 reference

12 December 2020

Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases

1 reference

12 December 2020

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

1 reference

12 December 2020

Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.

1 reference

12 December 2020

Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report

1 reference

12 December 2020

Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison.

1 reference

12 December 2020

Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential

1 reference

12 December 2020

Peritoneal papillary serous carcinoma with long-term survival

1 reference

12 December 2020

Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer

1 reference

12 December 2020

Extraovarian Brenner tumor

1 reference

12 December 2020

Probable pelvic mesothelioma. Report of a case and review of literature

1 reference

12 December 2020

Papillary serous carcinoma of the peritoneum

1 reference

12 December 2020

Prospectively detected cancer in familial breast/ovarian cancer screening.

1 reference

12 December 2020

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study

1 reference

12 December 2020

Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study

1 reference

12 December 2020

Variation in BRCA1 cancer risks by mutation position

1 reference

12 December 2020

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

1 reference

12 December 2020

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations

1 reference

12 December 2020

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

12 December 2020

Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis

1 reference

12 December 2020

Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium

1 reference

12 December 2020

Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma

1 reference

12 December 2020

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum

1 reference

12 December 2020

Role of p53 alteration in primary peritoneal carcinoma

1 reference

12 December 2020

Prevention of endometrial cancer with progestogens

1 reference

12 December 2020

Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group.

1 reference

12 December 2020

Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.

1 reference

12 December 2020

Frequency of BRCA Mutations in Primary Peritoneal Carcinoma in Israeli Jewish Women

1 reference

12 December 2020

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening

1 reference

12 December 2020

BRCA-associated breast cancer in young women

1 reference

12 December 2020

A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families

1 reference

12 December 2020

Clear cell carcinoma of the fimbria of the fallopian tube in a BRCA1 carrier undergoing prophylactic surgery

1 reference

12 December 2020

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

1 reference

12 December 2020

Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers

1 reference

12 December 2020

Management of borderline tumors of the ovary.

1 reference

12 December 2020

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

1 reference

12 December 2020

1 reference

12 December 2020

Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women

1 reference

12 December 2020

Ultrasound screening for familial ovarian cancer

1 reference

12 December 2020

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

1 reference

12 December 2020

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

1 reference

12 December 2020

Peritoneal mesothelioma

1 reference

12 December 2020

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

12 December 2020

Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study

1 reference

12 December 2020

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

12 December 2020

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients

1 reference

12 December 2020

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

12 December 2020

Postmenopausal hormone replacement therapy and atherosclerosis.

1 reference

12 December 2020

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

12 December 2020

Primary serous papillary carcinoma of the peritoneum: a report of 18 patients

1 reference

12 December 2020

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

1 reference

12 December 2020

Effects of estrogen and progestin on aortic size and compliance in postmenopausal women

1 reference

12 December 2020

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

1 reference

12 December 2020

Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors

1 reference

12 December 2020

Laparoscopy-assisted vaginal hysterectomy: report of seventy-five consecutive cases

1 reference

12 December 2020

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

12 December 2020

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan

1 reference

12 December 2020

Laparoscopic management of women with a family history of ovarian cancer

1 reference

12 December 2020

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer

1 reference

12 December 2020

Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence

1 reference

12 December 2020

Preserving cardiovascular benefits of hormone replacement therapy

1 reference

12 December 2020

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

12 December 2020

Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer

1 reference

12 December 2020

Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases

1 reference

12 December 2020

Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma

1 reference

12 December 2020

Overview of the main outcomes in breast-cancer prevention trials

1 reference

12 December 2020

Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum

1 reference

12 December 2020

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

1 reference

12 December 2020

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

12 December 2020

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

1 reference

12 December 2020

Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression

1 reference

12 December 2020

Prophylactic oophorectomy in inherited breast/ovarian cancer families

1 reference

12 December 2020

Cancer incidence in a population of Jewish women at risk of ovarian cancer

1 reference

12 December 2020

A critical analysis of laparoscopic assisted vaginal hysterectomies compared with vaginal hysterectomies unassisted by laparoscopy and transabdominal hysterectomies

1 reference

12 December 2020

An embryologically derived classification of ovarian tumors

1 reference

12 December 2020

A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities

1 reference

12 December 2020

Raloxifene, a new selective estrogen receptor modulator

1 reference

12 December 2020

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome

1 reference

12 December 2020

Effects of long-term estrogen replacement therapy. II. Neoplasia

1 reference

12 December 2020

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

12 December 2020

The ovarian mesothelioma

1 reference

12 December 2020

Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases

1 reference

12 December 2020

BRCA1 germline mutations in women with uterine serous papillary carcinoma

1 reference

12 December 2020

Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas

1 reference

12 December 2020

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

12 December 2020

A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas

1 reference

12 December 2020

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

12 December 2020

Hormone replacement and the prevention of cardiovascular disease

1 reference

12 December 2020

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

1 reference

12 December 2020

Cystic mucinous tumours of the mesentery and retroperitoneum: report of three cases

1 reference

12 December 2020

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors

1 reference

12 December 2020

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome

1 reference

12 December 2020

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

1 reference

12 December 2020

Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases

1 reference

12 December 2020

Primary clear cell carcinoma of the peritoneum

1 reference

12 December 2020

Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients

1 reference

12 December 2020

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

1 reference

12 December 2020

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Clinical potential of new antiestrogens

1 reference

12 December 2020

Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy

1 reference

12 December 2020

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

1 reference

12 December 2020

The secondary Müllerian system

1 reference

12 December 2020

Peritoneal papillary carcinoma

1 reference

12 December 2020

Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.

1 reference

12 December 2020

Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma

1 reference

12 December 2020

Breast cancer and BRCA1 mutations

1 reference

12 December 2020

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.

1 reference

12 December 2020

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

1 reference

12 December 2020

Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants

1 reference

12 December 2020

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

1 reference

12 December 2020

Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases

1 reference

12 December 2020

Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy

1 reference

12 December 2020

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

1 reference

12 December 2020

Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas

1 reference

12 December 2020

Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns

1 reference

12 December 2020

Epithelial ovarian tumors of low malignant potential: the role of microinvasion

1 reference

12 December 2020

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

12 December 2020

Association between endometrial cancer and tamoxifen treatment of breast cancer

1 reference

12 December 2020

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

1 reference

12 December 2020

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

12 December 2020

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

1 reference

12 December 2020

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

12 December 2020

Elevation of multiple serum markers in patients with stage I ovarian cancer.

1 reference

12 December 2020

Laparoscopic prophylactic oophorectomy in women with inherited risk of ovarian cancer

1 reference

12 December 2020

Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer

1 reference

12 December 2020

The differential diagnosis of primary peritoneal papillary tumors

1 reference

12 December 2020

Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum). A clinicopathologic study of 17 cases

1 reference

12 December 2020

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

1 reference

12 December 2020

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

12 December 2020

Evaluation of PAS-diastase and carcinoembryonic antigen staining in the differential diagnosis of malignant mesothelioma and papillary serous carcinoma of the ovary

1 reference

12 December 2020

Papillary peritoneal tumors in women

1 reference

12 December 2020

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

1 reference

12 December 2020

Genetics and ovarian carcinoma

1 reference

12 December 2020

Malignant mixed müllerian tumor of the extraovarian secondary müllerian system. Report of two cases and review of the English literature

1 reference

12 December 2020

Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma

1 reference

12 December 2020

Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases

1 reference

12 December 2020

Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds

1 reference

12 December 2020

The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer

1 reference

12 December 2020

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer

1 reference

12 December 2020

Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer

1 reference

12 December 2020

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

12 December 2020

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

1 reference

12 December 2020

Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

1 reference

12 December 2020

Intra-abdominal carcinomatosis with histologically normal ovaries

1 reference

12 December 2020

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

12 December 2020

Serous carcinoma of the peritoneum after oophorectomy

1 reference

12 December 2020

Papillary tumors of the peritoneum in women: mesothelioma or papillary carcinoma

1 reference

12 December 2020

The pathogenesis of ovarian neoplasia

1 reference

12 December 2020

BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.

1 reference

12 December 2020

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential

1 reference

12 December 2020

Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects

1 reference

12 December 2020

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

12 December 2020

Role of tumour markers in monitoring epithelial ovarian cancer

1 reference

12 December 2020

Peritoneal adenocarcinoma (serous) of Müllerian type: a subgroup of women presenting with peritoneal carcinomatosis

1 reference

12 December 2020

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

12 December 2020

10.1007/S10689-004-9554-Y

Identifiers

DOI

1 reference

11 August 2017

1 reference